Chemical Structure (Pomalidomide 01)
Chemical structure of Pomalidomide, showing its molecular framework with amine, carbonyl, and heterocyclic components.*
Pomalidomide Capsule
Product Images NDC 51991-342
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 51991-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pomalidomide 02)
A Kaplan-Meier survival curve chart showing progression-free survival over time in months for two groups: HD-DEX (blue line) and POM+LD-DEX (red dashed line). The y-axis represents the proportion of subjects surviving without progression, ranging from 0 to 1. A table below the graph indicates the number of subjects at risk at various time points for each group.*
Figure 2 (Pomalidomide 03)
A Kaplan-Meier survival curve chart comparing overall survival over months between two groups: HD-DEX (blue solid line) and POM+LD-DEX (red dashed line). The y-axis shows the proportion of subjects surviving, and the x-axis shows survival time in months. A table below the graph presents the number of subjects at risk over time for each group.*
Principal Display Panel (1 mg Capsule Bottle Label)
Label for Pomalidomide Capsules 1 mg, human prescription oral capsules. The label states dosage form and strength, contains a warning about potential for human birth defects, and lists the distributor as Breckenridge Pharmaceutical, Inc. and manufacturer as Natco Pharma Limited in India. The package contains 21 capsules and is marked Rx only.*
Principal Display Panel (2 mg Capsule Bottle Label)
Label for Pomalidomide Capsules 2 mg, a prescription oral capsule distributed by Breckenridge Pharmaceutical, Inc. and manufactured by Natco Pharma Limited. The label includes storage instructions, a pregnancy warning, barcode, and capsule quantity of 21. The NDC is 51991-343-21.*
Principal Display Panel (3 mg Capsule Bottle Label)
Label for Pomalidomide Capsules 3 mg by Breckenridge Pharmaceutical, Inc. The label includes storage instructions, a warning about potential human birth defects, and regulatory information such as the NDC 51991-344-21. It also states the capsule count (21 capsules) and emphasizes that the product is Rx only. Manufacturing details for Natco Pharma Limited in India are shown.*
Principal Display Panel (4 mg Capsule Bottle Label)
Label for Pomalidomide Capsules 4 mg by Breckenridge Pharmaceutical, Inc. The label states the active ingredient as Pomalidomide 4 mg per capsule, with storage instructions at 20°C to 25°C and allowances for excursions. It includes a warning about potential human birth defects and notes that 21 capsules are included in the package. The label also shows distributor and manufacturer information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
